MindWalk joins Russell 3000E ahead of Q4FY26 results on July 22

1 min read     Updated on 15 Jul 2026, 08:23 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

MindWalk Holdings Corp. will report Q4 and FY26 results on July 22, 2026, following its inclusion in the Russell 3000E Index and a European patent filing for its HYFT Technology.

powered bylight_fuzz_icon
45502503

*this image is generated using AI for illustrative purposes only.

MindWalk Holdings Corp. will report financial results for the fourth quarter and full fiscal year 2026 on July 22, 2026, following its recent addition to the Russell 3000E Index. The company, a Bio-Native AI firm listed on NASDAQ under the ticker HYFT, will release the results via press release prior to a scheduled conference call. The announcement will provide insights into the company's performance and recent business developments for the period, including its progress in GLP-1 metabolic health and infectious disease programs.

Conference Call Details

The earnings conference call is scheduled for Wednesday, July 22, 2026, at 5:00 p.m. Eastern Time. Management will present the financial results followed by a question-and-answer session. Investors and interested parties can access the live webcast and replay through the Events section of the company's Investor Relations pages.

Participation Information

Participants can join the call using the following dial-in numbers:

Region Dial-In Number
USA / International Toll +1 (646) 307-1963
USA Toll-Free (800) 715-9871
Canada (Toronto) (647) 932-3411
Canada Toll-Free (800) 715-9871

Strategic Developments

MindWalk was added to the Russell 3000E Index effective after the U.S. market close on June 26, 2026, broadening its eligibility for index-tracking funds. The company also filed a European patent application covering the high-dimensional data architecture behind its proprietary HYFT Technology and ReefIQ biological context layer. For the second quarter of fiscal 2026, the company reported revenue of approximately US$3.0 million, up 54% year over year, and gross profit up 94%. It divested non-core wet-lab operations in the Netherlands for approximately US$11.7 million in net proceeds to sharpen its focus on its AI platform.

About MindWalk Holdings Corp.

MindWalk Holdings Corp. focuses on building BioIntelligence infrastructure for life sciences AI and agentic AI. The company integrates AI, data, and advanced wet lab capabilities into a connected discovery ecosystem. Its core technology, HYFT, is a proprietary, function-aware representation of biology that spans sequence and structural biology. This technology supports products such as ReefIQ, a biological data substrate, and LensAI, a reasoning and application layer for target discovery and portfolio decision support.

How will inclusion in the Russell 3000E Index impact MindWalk's liquidity and institutional investor base over the next year?

What specific milestones does the company aim to achieve in its GLP-1 metabolic health and infectious disease programs by the end of fiscal 2026?

How does MindWalk plan to allocate the $11.7 million in net proceeds from the divestiture of its wet-lab operations to scale its AI platform?

like18
dislike

MindWalk Holdings files $250M shelf registration statement

1 min read     Updated on 14 Jul 2026, 03:04 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

MindWalk Holdings filed a $250M shelf registration statement with the SEC, featuring a $50M At-The-Market sales agreement. The filing provides flexibility for future capital raises.

powered bylight_fuzz_icon
45524044

*this image is generated using AI for illustrative purposes only.

MindWalk Holdings filed a shelf registration statement with the U.S. Securities and Exchange Commission (SEC) to offer up to $250M in securities. The filing includes a prospectus supplement for a $50M At-The-Market (ATM) sales agreement. This registration allows the company to offer various securities from time to time.

The shelf registration statement provides flexibility for MindWalk Holdings to raise capital through different types of securities, such as debt, common stock, or preferred stock. The $50M ATM sales agreement specifically permits the sale of shares directly into the trading market at prevailing market prices.

The SEC filing outlines the terms of the offering and the use of proceeds, though specific details on the allocation of funds were not disclosed in the initial document. The ATM component provides a mechanism for the company to access capital quickly without the need for a traditional underwritten offering.

Key Details of the Filing

Component Amount
Total Shelf Registration $250M
At-The-Market Sales Agreement $50M

The registration statement on Form S-3 was filed with the SEC. The prospectus supplement for the ATM agreement details the terms under which the selling agents may offer and sell the shares.

How will the issuance of new shares through the ATM agreement impact MindWalk Holdings' existing stock price and shareholder dilution?

What strategic initiatives or acquisitions is MindWalk Holdings planning to fund with the raised capital?

How quickly does the company intend to utilize the $50M ATM facility, and what market conditions might influence the timing?

like17
dislike

More News on MindWalk Holdings Corp